Literature DB >> 20549567

Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California.

Alex H Kral1, Richard S Garfein.   

Abstract

Mesh：

Year:  2010        PMID： 20549567      PMCID： PMC2900576          DOI： 10.1007/s11524-010-9485-x

Source DB:  PubMed          Journal:  J Urban Health        ISSN： 1099-3460            Impact factor:   3.671


× No keyword cloud information.
  15 in total

1.  Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

Authors:  Enrique R Pouget; Sherry Deren; Crystal M Fuller; Shannon Blaney; James M McMahon; Sung-Yeon Kang; Stephanie Tortu; Jonny F Andia; Don C Des Jarlais; David Vlahov
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

2.  Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

Authors:  Charles M Cleland; Sherry Deren; Crystal M Fuller; Shannon Blaney; James M McMahon; Stephanie Tortu; Don C Des Jarlais; David Vlahov
Journal:  Health Educ Behav       Date:  2006-06-30

3.  The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.

Authors:  Sherry Deren; Charles M Cleland; Crystal Fuller; Sung-Yeon Kang; Don C Des Jarlais; David Vlahov
Journal:  AIDS Behav       Date:  2006-11

4.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

5.  Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.

Authors:  L A Valleroy; B Weinstein; T S Jones; S L Groseclose; R T Rolfs; W J Kassler
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

6.  Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Authors:  L Wright-De Agüero; B Weinstein; T S Jones; J Miles
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

7.  Injection drug users report good access to pharmacy sale of syringes.

Authors:  Wendy Reich; Wilson M Compton; Joeseph C Horton; Linda B Cottler; Renee M Cunningham-Williams; Robert Booth; Merrill Singer; Carl Leukefeld; Joseph Fink; Tom J Stopka; Karen Fortuin Corsi; Michelle Staton Tindall
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

8.  Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.

Authors:  M Singer; H A Baer; G Scott; S Horowitz; B Weinstein
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

9.  Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.

Authors:  S L Groseclose; B Weinstein; T S Jones; L A Valleroy; L J Fehrs; W J Kassler
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

10.  Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007.

Authors:  Erin N Cooper; Chaka Dodson; Thomas J Stopka; Elise D Riley; Richard S Garfein; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671
View more
  2 in total

1.  Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Authors:  Alexandra Lutnick; Patricia Case; Alex H Kral
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

2.  Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.

Authors:  Alexandra Lutnick; Erin Cooper; Chaka Dodson; Ricky Bluthenthal; Alex H Kral
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.